Skip to content

MEDIBOIS 261: what changed

BE 0721.956.548NACE 86.210, General medical practiceOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€7,271
2024 · €7,519-€248
Equity
-€5,967
2024 · -€13,238+€7,271
Cash
€1,127
2024 · €2,049-€922
Balance sheet total
€208,212
2024 · €237,357-€29,145

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets -€24,171

    down €24,171 (-10.6%), from €227,050 to €202,879

    of which Other tangible fixed assets: -€22,371

  • Deferred charges and accrued income -€4,053

    down €4,053 (-49.1%), from €8,258 to €4,205

Equity and liabilities
  • Debts after one year -€45,156

    down €45,156 (-27.7%), from €162,746 to €117,590

  • Profit (loss) carried forward +€7,271

    up €7,271 (+36.8%), from -€19,738 to -€12,467

  • Other debts +€6,623

    up €6,623 (+18.9%), from €34,967 to €41,590

Income statement
  • Staff costs +€2,192

    up €2,192 (+5.6%), from €38,939 to €41,131

  • Depreciation -€1,032

    down €1,032 (-4.1%), from €25,203 to €24,171

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 €7,519
Gross operating margin +€618
Staff costs -€2,192
Depreciation +€1,032
Other operating charges -€15
Financial charges +€309
Result 2025 €7,271
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€43,638
Investment €0
Financing -€44,560
Cash 2024 €2,049
Net result for the year +€7,271
Depreciation +€24,171
Deferred charges and accrued income +€4,053
Trade debts +€1,408
Tax, wage and social debts +€113
Other debts +€6,623
Debts after one year -€45,156
Current portion of long-term debt +€596
Cash 2025 €1,127
brings cash intakes cash out
Every line side by side 32 lines
Line Code 2024 2025 Change %
Total assets 20/58 €237,357 €208,212 -€29,145 -12.3%
Fixed assets 21/28 €227,050 €202,879 -€24,171 -10.6%
Tangible fixed assets 22/27 €227,050 €202,879 -€24,171 -10.6%
Furniture and vehicles 24 €3,513 €1,713 -€1,800 -51.2%
Other tangible fixed assets 26 €223,537 €201,166 -€22,371 -10.0%
Current assets 29/58 €10,307 €5,333 -€4,974 -48.3%
Cash at bank and in hand 54/58 €2,049 €1,127 -€922 -45.0%
Deferred charges and accrued income 490/1 €8,258 €4,205 -€4,053 -49.1%
Total equity and liabilities 10/49 €237,357 €208,212 -€29,145 -12.3%
Equity 10/15 -€13,238 -€5,967 +€7,271 +54.9%
Contributions 10/11 €6,500 €6,500 = 0.0%
Profit (loss) carried forward 14 -€19,738 -€12,467 +€7,271 +36.8%
Amounts payable 17/49 €250,595 €214,179 -€36,416 -14.5%
Amounts payable after more than one year 17 €162,746 €117,590 -€45,156 -27.7%
Financial debts 170/4 €162,746 €117,590 -€45,156 -27.7%
Amounts payable within one year 42/48 €87,848 €96,589 +€8,740 +9.9%
Current portion of amounts payable after more than one year 42 €41,109 €41,706 +€596 +1.5%
Trade debts 44 €5,950 €7,358 +€1,408 +23.7%
Suppliers 440/4 €5,950 €7,358 +€1,408 +23.7%
Taxes, remuneration and social security 45 €5,823 €5,935 +€113 +1.9%
Remuneration and social security 454/9 €5,823 €5,935 +€113 +1.9%
Other amounts payable 47/48 €34,967 €41,590 +€6,623 +18.9%
Remuneration, social security and pensions 62 €38,939 €41,131 +€2,192 +5.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €25,203 €24,171 -€1,032 -4.1%
Other operating charges 640/8 €549 €564 +€15 +2.7%
Gross operating margin 9900 €75,531 €76,149 +€618 +0.8%
Operating profit (loss) 9901 €10,840 €10,283 -€557 -5.1%
Financial charges 65/66B €3,321 €3,012 -€309 -9.3%
Recurring financial charges 65 €3,321 €3,012 -€309 -9.3%
Profit (loss) for the period before taxes 9903 €7,519 €7,271 -€248 -3.3%
Profit (loss) for the period 9904 €7,519 €7,271 -€248 -3.3%
Profit (loss) for the period to be appropriated 9905 €7,519 €7,271 -€248 -3.3%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice
€45,302 to €64,616

Midpoint €53,350 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

Adjusted equity -€5,967
Capitalised earnings €96,571 to €135,200
Indication €45,302 to €64,616

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
-€5,967
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
-€5,967

Capitalised earnings

net result for the year (9904)
2025
€7,271
2024
€7,519
2023
€25,769
2022
€2,621
2021
-€2,032
Average result
€13,520
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€96,571 / €112,667 / €135,200

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 20 November 2026 via checked.be.